JP2013256473A5 - - Google Patents

Download PDF

Info

Publication number
JP2013256473A5
JP2013256473A5 JP2012134048A JP2012134048A JP2013256473A5 JP 2013256473 A5 JP2013256473 A5 JP 2013256473A5 JP 2012134048 A JP2012134048 A JP 2012134048A JP 2012134048 A JP2012134048 A JP 2012134048A JP 2013256473 A5 JP2013256473 A5 JP 2013256473A5
Authority
JP
Japan
Prior art keywords
formula
hydrogen atom
compound represented
hydroxyl group
methyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012134048A
Other languages
English (en)
Japanese (ja)
Other versions
JP6061508B2 (ja
JP2013256473A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012134048A priority Critical patent/JP6061508B2/ja
Priority claimed from JP2012134048A external-priority patent/JP6061508B2/ja
Publication of JP2013256473A publication Critical patent/JP2013256473A/ja
Publication of JP2013256473A5 publication Critical patent/JP2013256473A5/ja
Application granted granted Critical
Publication of JP6061508B2 publication Critical patent/JP6061508B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012134048A 2012-06-13 2012-06-13 Trpa1活性抑制剤 Active JP6061508B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012134048A JP6061508B2 (ja) 2012-06-13 2012-06-13 Trpa1活性抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012134048A JP6061508B2 (ja) 2012-06-13 2012-06-13 Trpa1活性抑制剤

Publications (3)

Publication Number Publication Date
JP2013256473A JP2013256473A (ja) 2013-12-26
JP2013256473A5 true JP2013256473A5 (enExample) 2014-10-09
JP6061508B2 JP6061508B2 (ja) 2017-01-18

Family

ID=49953237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012134048A Active JP6061508B2 (ja) 2012-06-13 2012-06-13 Trpa1活性抑制剤

Country Status (1)

Country Link
JP (1) JP6061508B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6410352B2 (ja) * 2014-10-10 2018-10-24 花王株式会社 刺激感緩和剤
JP6804162B2 (ja) * 2018-09-14 2020-12-23 株式会社マンダム 皮膚外用剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003206239A (ja) * 2001-12-28 2003-07-22 Lion Corp 温感組成物及び外用剤組成物
JP2007077143A (ja) * 2005-08-19 2007-03-29 Rohto Pharmaceut Co Ltd アシタザノラスト含有組成物
CN101292976B (zh) * 2008-06-26 2010-07-28 贵州宏宇药业有限公司 一种含有1,8-桉叶素和艾纳香素的药物组合物及其用途
RU2573293C2 (ru) * 2010-03-26 2016-01-20 Филип Моррис Продактс С.А. Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов

Similar Documents

Publication Publication Date Title
WO2012085523A3 (en) Skin sanitizer compositions comprising alcohol based emulsion
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
MX2014011181A (es) Microemulsiones basadas en ciclodextrina y usos dermatologicos de las mismas.
EP2629799A4 (en) TOPICAL BASE AND ACTIVE COMPOSITIONS AND PROCESS FOR THE CARE AND TREATMENT OF THE SKIN
CO6690744A2 (es) Formulación de polvo seco que comprende un inhibidor de fosfodiesterasa
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2009107072A8 (en) Hair care compositions and methods for increasing hair diameter
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
AR091739A1 (es) Composiciones y metodos para reducir el riesgo cardiometabolico
ME02199B (me) Nova farmaceutska formulacija za tretman gljivičnih infekcija
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
HK1206621A1 (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof
JP2013253067A5 (enExample)
AR089812A1 (es) Agente terapeutico para la diabetes mellitus
BR112014007177A2 (pt) agente antifúngico
JP2013256473A5 (enExample)
WO2011159439A3 (en) Skin moisturizer
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
RU2013110517A (ru) Средство для профилактики или лечения неалкогольного стеатогепатита
JP2015521599A5 (enExample)
MX2016006480A (es) Composicion antitranspirante.
WO2013068960A3 (en) Monounsaturated fatty acid for nailcare
PH12017501336B1 (en) Preventive and/or therapeutic agent of immune disease
MY169094A (en) Methanethione compounds having antiviral activity
WO2013068962A3 (en) Monounsaturated fatty acid for nailcare